GHK-Cu and Infection-Related Readouts in Wound Contexts Mouse and clinical datasets point to a possible reduction in inflammatory proteases (for example, MMP-2/9) and cytokines (such as TNF-) in wounds exposed to GHK-Cu, aligning with lower observed infection rates in comparative ulcer care cohorts
Because no head-to-head trial exists, no one can validly claim that retatrutide beats cagrilintide (or vice versa) by any specific margin
Then, they get weekly shots
Age-related considerations include: Younger adults (18-30) May tolerate dose escalation well but should still follow standard protocols
However, a longer duration of therapy should not preclude the possibility of an association to the drug since most studies included in the analysis did not continue beyond 24 weeks
Both are early enough in development that the published endpoints are surrogates body weight, HbA1c, liver fat measured over trial-length follow-up